Human Gene Therapy

译名:人类基因治疗

HUMAN GENE THERAPY

SCIEJCR Q1

3-5

2026

影响因子区间

平台估算

投稿周期

4%

2025

中国作者发文占比

£3490.00 GBP / $5090.00 USD / €3990.00 EUR.

费用说明

收费

期刊简介:Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.

【译文】《人类基因治疗》是一本领先的多学科期刊,涵盖了基因治疗的各个方面。该期刊通过提供最新的研究和技术突破,对DNA、RNA和细胞疗法进行深入报道。人类基因治疗提供了一个中心论坛,用于科学和临床信息,包括伦理、法律、监管、社会和商业问题,这有助于推进治疗程序,改善患者预后,最终治愈疾病。

出版社
Mary Ann Liebert, Inc.
语言
English
学科
医学
ISSN
1043-0342
eISSN
1557-7422
出版频率
半月刊
创刊年份
1990
投稿网址
http://www.liebertpub.com/forauthors/human-gene-therapy/19/
最近更新
2026-04-02 18:16:40
Human Gene Therapy

指标当前值近三年趋势
JCR分区Q1
暂无
影响因子区间3-5
暂无